Benzinga | Jun 21, 2021 07:04AM EDT

Wells Fargo Maintains Equal-Weight on Exact Sciences, Raises Price Target to $120

Wells Fargo analyst Dan Leonard maintains Exact Sciences (NASDAQ:EXAS) with a Equal-Weight and raises the price target from $115 to $120.